Results 101 to 110 of about 37,527 (263)
Yu-Cheng Cheng,1 Yu-Hsuan Li,1,2 Chiann-Yi Hsu,3 I-Te Lee1,4– 6 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; 2Graduate Institute of Data Science, Taipei Medical ...
Cheng YC, Li YH, Hsu CY, Lee IT
doaj
Background: Serum carbohydrate antigen (CA19-9) is a tumour marker which is significantly elevated in biliary and pancreatic malignancy. It is also increased in some benign conditions associated with jaundice. So many strategies have been recommended to improve the power of CA 19-9 to differentiate benign and malignant obstructive jaundice.
Mohammad Golam Azam +5 more
openaire +1 more source
Semi-Parametric Maximum Likelihood Estimates for ROC Curves of Continuous-Scale Tests [PDF]
In this paper, we propose a new semi-parametric maximum likelihood (ML) estimate of an ROC curve that satisfies the property of invariance of the ROC curve and is easy to compute.
Lin, Huazhen, Zhou, Xiao-Hua
core +3 more sources
ABSTRACT A 49‐year‐old male developed liver dysfunction during chemotherapy for rectal cancer located in the rectosigmoid region. Although magnetic resonance cholangiopancreatography initially indicated sclerosing cholangitis, endoscopic retrograde cholangiopancreatography and intraductal ultrasonography revealed multiple non‐contiguous intraductal ...
Shinji Monoe +5 more
wiley +1 more source
Introduction CA19-9 is one of the most important tumor markers used in patients with colorectal cancer, mainly in radical surgery follow-up. Aim: The purpose of this study was to evaluate the preoperative CA19-9 level obtained from a peripheral vein (PV)
N. M. Forones, M. Tanaka, D. Matos
doaj +1 more source
IMMUNOHISTOLOGICAL STUDIES OF TUMOR MARKER CA19-9
Immunohistological examination of tumor tissues using monoclonal antibody CA19-9 was performed in 20 cases including 4 pancreatic cancer, 6 bile duct cancer, 4 gastric cancer, 3 papillary cancer, 1 duodenal cancer, 1 colon cancer and 1 ovarian teratoma.
Seiichiro ANDOH +5 more
openaire +2 more sources
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer [PDF]
AIM: To investigate activity, toxicity, and prognostic factors for survival of erlotinib and fixed dose-rate gemcitabine (FDR-Gem) in advanced pancreatic cancer.
Bria, E. +9 more
core +1 more source
Abstract While hepatocellular carcinoma (HCC) often invades the portal or hepatic vein to form tumor thrombus, tumor thrombus in the bile duct is rare. In such cases, differentiation from intrahepatic cholangiocarcinoma is difficult, and the tumor often appears as a smooth, yellowish‐white, polypoid mass within the bile duct lumen.
Keisuke Kinoshita +9 more
wiley +1 more source
Background: CA19-9 is among a group of mucin glycoprotein sialosyl lewis antigen (SLA) having come to be recognized as a circulating cancer associated antigen for gastrointestinal cancer.
Amar H. Al-dujaili +3 more
doaj +1 more source
Prostate cancer with high serum level of CEA and CA19-9: a case report [PDF]
症例は80歳男で, 食欲不振を主訴とする.入院時血清CEA, CA19-9, 血清PSAは高値を示していた.CTにて大動脈周囲のリンパ節腫脹を認め, 骨シンチでは多発性骨転移を認めた.前立腺針生検で悪性所見を認めなかった.前立腺癌が疑われ, 内分泌療法を開始したが, 2ヵ月後に死亡した.剖検試料は組織学的に前立腺癌(低分化型腺癌)であり, 肺, 肝, 甲状腺, 骨髄, 副腎に転移を認めたWe report a case of primary adenocarcinoma of the prostate ...
小野田, 登 +3 more
core

